Nureca Limited has received warning letters from both BSE Limited and National Stock Exchange of India Limited for failing to comply with mandatory committee meeting requirements under SEBI regulations. The company disclosed this development on January 07, 2026, pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory Non-Compliance Details

The warning letters were issued for the company's failure to hold any meeting of the Stakeholder's Relationship Committee during the Financial Year ended 2024-25. This constitutes a violation of Regulation 20(3A) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which specifically mandates that the stakeholders relationship committee shall meet at least once in a financial year.

Exchange Communications

BSE Limited issued its warning letter on January 06, 2026, stating that the non-compliance has been viewed seriously. The exchange advised the company to exercise greater diligence and take immediate corrective measures to prevent recurrence of such lapses. BSE emphasized the imperative to ensure strict adherence to all applicable exchange circulars, guidance notes, and communications.

National Stock Exchange of India Limited followed with its warning letter on January 07, 2026. NSE warned the company and advised it to be careful in future, exercise due caution, and initiate corrective steps to avoid recurrence of such lapses to ensure due compliance with SEBI LODR and exchange communications.

Regulatory Requirements and Next Steps

Both exchanges have mandated specific actions from Nureca Limited:

• Dissemination of the warning letters on all stock exchanges where the company is listed
• Presentation of the warning letters before the Board of Directors
• Implementation of corrective measures to avoid future lapses
• Ensuring strict compliance with all applicable regulations

Both BSE and NSE have clearly stated that any future deviation will be viewed with utmost seriousness and may attract appropriate action as deemed necessary. The exchanges have emphasized the need for the company to ensure due compliance with SEBI LODR regulations and exchange communications going forward.

Company Response

The disclosure was signed by Nishu Kansal, Company Secretary & Compliance Officer (M.No. A33372), on January 07, 2026. The company has acknowledged receipt of both warning letters and confirmed that there is no quantifiable financial impact from this regulatory action on the company's financial, operational, or other activities.

Nureca Limited has announced the relocation of its registered office within Mumbai, marking a significant administrative development for the healthcare and consumer products company. The shift became effective on December 10, 2025, as communicated to both major stock exchanges.

Office Relocation Details

The company has moved its registered office from the eastern suburbs to the western part of Mumbai. This transition represents a strategic administrative decision that may enhance operational efficiency and accessibility.

Regulatory Compliance

Nureca Limited has fulfilled its regulatory obligations by promptly informing the stock exchanges about this corporate action. The notification was filed pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates listed companies to disclose material events and corporate developments.

The communication was signed by Nishu Kansal, Company Secretary and Compliance Officer (Membership No. A33372), ensuring proper authorization and compliance with corporate governance standards. The digital signature was applied on December 10, 2025, at 17:02:23.

Corporate Structure

While the registered office has been relocated, Nureca Limited maintains its correspondence office at SCO 6-7-8, 1st Floor, Madhya Marg, Sector 9-D, Chandigarh-160009. The company continues to operate under CIN L24304MH2016PLC320868 and can be reached at phone number 91-172-5292900.

Stock Exchange Information

The company has requested both BSE Limited and National Stock Exchange of India Limited to take note of this information and arrange for its proper dissemination to market participants.

This administrative change reflects the company's ongoing operational adjustments and commitment to maintaining transparent communication with regulatory authorities and stakeholders.